Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
51 results about "Whole blood viscosity" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Whole blood viscosity is the ability of the blood to flow, which determines the burden of work to the heart in pumping blood, the physical injury that blood can cause against the inner lining of the arteries, and the delivery of oxygen to the organ systems.
Coarse food mixing bean flour
InactiveCN101390585AMeet special requirementsDough treatmentFood preparationBiotechnologyESR - Erythrocyte sedimentation rate
The invention relates to a kind of flour, in particular to a coarse grain mixed bean flour, wherein, the mixed bean flour comprises brown rice flour, corn flour, black rice flour, black sesame powder, soybean powder, peanut powder, millet flour, sorghum flour, potato powder, sunflower seed powder, walnut powder, pine nut powder, lotus seed powder, and Gordon euryale seed powder; or the mixed bean flour comprises wheat kernel powder, black sesame powder, soybean flour, peanut flour, sunflower seed powder, walnut powder and pine nut powder; or the mixed bean flour comprises brown rice flour, pearl barley powder, lotus seed powder and Gordon euryale seed powder. The preparation method of the coarse grain mixed bean flour adds three processing procedures on the processing method of ordinary flour production, namely, stir-frying, weighing and mixing. The coarse grain mixed bean flour has good therapeutic effects on abnormal blood glucose, whole-blood viscosity, ESR erythrocyte sedimentation rate, erythrocyte sedimentation rate equation K and other indexes; besides, the raw materials of the mixed bean flour are reasonably matched and low in price as well as rich in taste; the coarse grain mixed bean flour can be consumed by people of various ages and is an ideal product to replace the existing flour made of single material.
Owner:王斌
Double-station full-automatic rheogeniometer
InactiveCN101846612AProcessing speedImprove efficiencyDirect flow property measurementTester deviceEngineering
The invention discloses a double-station full-automatic rheogeniometer, comprising a case, test components, a cleaning device and a control device, wherein, the two sets of the test components are arranged on the operating surface of the case, and each set of the test components comprise a test tube tray, a sampling arm, cone plate-type whole blood test components, a capillary tube type plasma test components and a corresponding control device. When a set of system tests the whole blood viscosity and simultaneously the other set of system measures the plasma viscosity, the two sets of systems can be replaced mutually and reserved mutually and also can work independently; and the measuring result can enter into a report through the system data integration, and is printed together, and the invention has the characteristics of rapid process and high efficiency for test work of a large amount of blood samples.
Owner:北京众驰伟业科技发展有限公司
Sulfonated changium root polysaccharides and preparing method and use thereof
InactiveCN1844160ANovel preparation processLow costOrganic active ingredientsAntineoplastic agentsChangiumSulfated polysaccharides
In this invention, we extract raw polysaccharides from changium root named A B C respectively, and purify to get 6 polysaccharides I,II,III,IV,V,VI. After sulfation, we get sulfated polysaccharides A1, B1,C1. A1 has two sulfate groups on each monosaccharide at the average while B1 and C1 have three. The sulfated polysaccharides' molecular weight is more than 2 million D. The glycoside link is alpha type. The whole procedure of changium root sulfated polysaccharides is as followings: extract raw polysaccharides from changium root, and then get the polysaccharides sulfated. It is advantageous in simplied-manipulation and low cost. The pharmacological experiments prove its obvious suppression on rat transplanting tumor(S-180) and the reduction of platelet aggregation ratio and whole blood viscosity. It also reduces coagulant time.
Owner:NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
Method and device for detecting blood viscosity and hematocrit by using one instrument
ActiveCN101995364AReduce usageReduce cleaning workloadVolume measurement apparatus/methodsDirect flow property measurementMeasurement deviceAutomatic control
The invention relates to a method and a device for detecting blood viscosity and hematocrit by using one instrument. In the invention, full-automatic detection equipment, including a stirring pin device, a sample loading pin device, a capillary viscosity measurement device, a rotary type blood rheological measurement device, a hematocrit scanning measurement device, a computer device based automatic control circuit and a matched program of the automatic control circuit is used. The detection method comprises the following steps of: collecting a patient blood sample, carrying out anticoagulant processing, injecting into a sample tube, and centrifuging; putting the sample tube in a sample tube frame, conveying the sample tube frame to a hematocrit test position for detecting, and storing hematocrit data; conveying the sample tube frame to a blood viscosity test position for detecting plasm viscosity and storing data; stirring the blood sample into whole blood by the stirring pin device, and reading the blood viscosity data by the rotary type blood rheological measurement device; and processing the detected data by a resolving processor. By using the full-automatic detection manner disclosed in the invention, operators avoid contacting the patient blood sample directly and cannot be polluted, all the processes of sample loading process, detection process and cleaning process are all accomplished by instruments automatically, thereby improving the detection speed and accuracy of clinical examination.
Owner:BEIJING PRECIL INSTR CO LTD
Non-Newtonian fluid viscosity standard substance and preparation method thereof
ActiveCN103344476AHigh simulationImprove accuracyFlow propertiesPreparing sample for investigationMetrologyPolyethylene oxide
The invention belongs to the field of metrology science, relates to a non-Newtonian fluid viscosity standard substance and a preparation method thereof, and particularly relates to a whole blood viscosity standard substance and a preparation method thereof. The non-Newtonian fluid viscosity standard substance provided by the invention includes, by mass: 0.1% to 3.44% of polyethylene oxide, 0.25% to 2.5% of nano SiO2 colloidal particles, and the balance being water. The non-Newtonian fluid viscosity standard substance is a typical non-Newtonian fluid having a shear-thinning characteristic at low shear rates, can better simulate whole blood fluid characteristics, and thereby being used as the whole blood viscosity standard substance; and because of interaction between the SiO2 colloidal particles and polyethylene oxide molecular chains, the non-Newton fluid viscosity standard substance has good stability and uniformity.
Owner:NAT INST OF METROLOGY CHINA +1
Preparing process for Chinese medicine for treating vocal nodules and polyp of vocal cord and its use
ActiveCN1899569AIncrease chlorogenic acid contentIncrease profitAnthropod material medical ingredientsBird material medical ingredientsChlorogenic acidPlatelet adhesiveness
The present invention relates to Chinese medicine preparation, and is especially the preparation process and application of Chinese medicine preparation for treating vocal nodules and polyp of vocal cord. The preparation process of the present invention is stable, practical, high material utilizing rate and high effective component extracting rate, and the Chinese medicine preparation has high chlorogenic acid content. The Chinese medicine preparation has the functions of promoting blood circulation to disperse blood clots, lowering blood viscosity, lowering fibrinogen content and platelet adhesiveness, and inhibiting proliferation of granulation tissue.
Owner:XIAN BEILIN PHARMA
Compound combination of Chinese traditional medicine in use for lowering viscosity of whole blood, thrombolysis and reducing blood fat
InactiveCN1660420AReduce blood viscosityReduce thrombolysisPeptide/protein ingredientsMetabolism disorderWhole blood unitsThrombus
A Chinese medicine for decreasing blood viscosity and blood fat and dissolving thrombus contains arasaponin, earthworm kinase and theapolyphenol.
Owner:KUNMING SHENGHUO PHARMA GRP
Application of pyrroloquinoline quinone (PQQ) in treatment and/or improvement of diabetic foot
ActiveCN103191115ATreatment safetyEffective treatmentOrganic active ingredientsMetabolism disorderDiabetic complicationGangrene
The invention provides an application of a pyrroloquinoline quinone (PQQ) active substance in preparation of medicaments for treating and / or improving a diabetic complication, namely diabetic foot and further provides a health-care product composition or a pharmaceutical composition containing pyrroloquinoline quinone. The active substance, namely the pyrroloquinoline quinone in the composition provided by the invention has significant treatment and / improvement action against the diabetic complication, namely the diabetic foot by improving nerve conduction velocity, reducing sorbitol content, increasing the open number of capillaries, reducing whole blood viscosity, enhancing blood flow, increasing neural blood flow, promoting blood circulation, improving microcirculation of blood vessels and reducing gangrene ulcers of the foot. Therefore, the pyrroloquinoline quinone has great application prospects in prevention, treatment and / or improvement of occurrence and development of the diabetic complication, namely the diabetic foot.
Owner:SHANGHAIMED
Medicament for treating coronary heart disease and angina and preparation method of granular formulation thereof
InactiveCN101658567ANormal activitySmooth furGranular deliveryCardiovascular disorderSalvia miltiorrhizaCoronary artery disease
Owner:SHAANXI HUALONG PHARMA
Pharmaceutical composition for treating chloasma and preparation method thereof
ActiveCN104173607ASymptoms improvedLower whole blood viscosity valuesDermatological disorderPlant ingredientsLiver and kidneySide effect
The invention relates to a pharmaceutical composition for treating chloasma and a preparation method thereof. The pharmaceutical composition is mainly prepared from fructus ligustri lucidi, herba ecliptae, radix salviae miltiorrhizae, angelica sinensis, cinnamomum cassia, rose and a grape seed extract. The pharmaceutical composition has the efficacies of nourishing liver and kidney, removing blood stasis and eliminating spots, and is suitable for patients with chloasma. Clinical studies show that the pharmaceutical composition can obviously improve symptoms of the patients with melasma, has the clinical total effective rate of 91.43% and has no toxic or side effect; and experimental studies show that the pharmaceutical composition can obviously reduce the chloasma mouse whole blood viscosity, improves the blood consistence, increases the activity of free radical scavenging enzymes, decreases lipid peroxidation, and reduces the formation of melanin.
Owner:BEIJING UNIV OF CHINESE MEDICINE +1
Medicament composition and preparation method for treating chronic glomerulonephritis
ActiveCN101632772AUrinary disorderLeech/worm material medical ingredientsCreatinine riseTotal protein
The invention discloses a medicament composition and a preparation method for treating chronic glomerulonephritis. The medicament composition comprises the components of raw material medicament based on portions by weight: 450 to 550 portions of milk veteh, 200 to 300 portions of angelica, 330 to 430 portions of yam, 200 to 300 portions of bupleurum, 250 to 350 portions of pyrrosia lingua, 250 to 350 portions of umbellate pore furgus and 50 to 100 portions of leech. The medicament composition has obvious effect on treating chronic glomerulonephritis, raises high cutting and low cutting of whole blood viscosity, blood plasma and red cell accumulation, reduces the levels of the total protein and the albumin of blood, raises the levels of the nitrogen and the creatinine of blood urea, improves blood haemorheology and raises urinary output by 3h and total urinary output.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL
Antithrombotic medicine
InactiveCN105998194AClear antithrombotic effectProlong clotting timeBlood disorderExtracellular fluid disorderCannabinoidMedicine
The invention discloses an antithrombotic medicine. The antithrombotic medicine is prepared by evenly mixing, by weight, 0.3-99.7 parts of fructus cannabis extract and 99.7-0.3 part of industrial cannabinoid. Experiments show that the medicine has a remarkable antithrombotic effect, can remarkably suppress formation of thrombus in the bodies of rats, has a remarkable suppressing effect on platelet aggregation of rats, can remarkably delay the blood coagulation time of rats, can reduce the whole blood viscosity, plasma viscosity and packed cell volume of rats, has a better acting effect than cannabidiol, and has good application prospects.
Owner:云南瑞酚生物科技有限公司
Muscle and bone plaster
InactiveCN103948724AReduce blood viscosityAccelerated dissipationHydroxy compound active ingredientsAntipyreticRhizomePlatelet inhibition
The invention discloses a muscle and bone plaster, which comprises a patch on which a plaster layer is arranged, and is characterized in that the plaster layer comprises the materials of: prepared radix aconiti, prepared kusnezoff monkshood root, nux vomica, epimedium herb, root of bidentate achyranthes, notopterygium root, cyrtomium fortunei, golden cypressc, zaocys dhumnade, curnu cervi pantotrichum, teasel root, dark plum, asarum, ephedra, cassia twig, red flower, acanthopanax root, honeysuckle, lumbricus, loranthus parasiticus, liquorice, drynaria rhizome, anisetree bark, myrrh, red ginseng, mint, borneol and ligusticum wallichii; and the muscle and bone plaster is prepared by decocting the medical herbs to obtain extract and coating the patch with the extract. The muscle and bone plaster has effects on resisting soft tissue injury, resisting inflammatory, easing pain and promoting blood circulation to remove blood stasis, can reduce whole blood viscosity and inhibit platelet aggregation, and also has inhibiting effect on the increase of the permeability of celiac capillaries caused by acetic acid.
Owner:TONGHUA WANTONG PHARMACY
Novel use of total flavone of effective component of Cotinus coggygria and preparation
InactiveCN101474220AImprove hypoxia toleranceIn vitro anticoagulantCardiovascular disorderPlant ingredientsSide effectTreatment effect
One of the tasks of the invention is to define an effective part for using cotinus coggygria, and provide pharmacodynamics usages of the effective part and various preparations. The new usage of the effective part of the cotinus coggygria is that the leaves, stems, branches and roots of the cotinus coggygria are collected to extract general flavone as a drug which can improve animal organism hypoxia tolerance or thrombolysis, etc. The invention has the advantages that the effective part of the cotinus coggygria is defined, and the effective components are separated for medical use, thus obviously improving the therapeutic effect. Experiments prove that the preparation of the invention can obviously improve animal hypoxia tolerance and the effect thereof is equal to a western medicine antianginal drug Propranolol, thus avoiding the toxic side effect of the western medicine and having the actions of improving blood circulation and reducing whole blood viscosity. Therefore, the preparation can be applicable for preventing and curing coronary heart disease, angina pectoris, miocardial infarction, as well as obstruction of Qi in chest, dizziness, brachypnea, palpitation, chest distress or thoracodynia caused by internal resistance of congestion. Meanwhile, the preparation of the invention also has the actions of anticoagulation in vitro and thrombus dissolving.
Owner:崔恩贤
Viscosity modulating substance and use thereof
It has now been found that N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM) lowers whole blood viscosity in patient, including those suffering from sickle cell disease and plasma cell dyscrasias. Upon in vivo APM treatment patients experienced a significant lowering of whole blood viscosity. In vitro addition of APM to patients samples having elevated whole blood viscosity resulted in reduced viscosity over time. These in vivo and in vivo results identify APM as a therapeutic agent for molecular diseases which lead to elevated whole blood viscosity. A method by which APM treatment can be monitored is also disclosed.
Owner:OKLAHOMA MEDICAL RES FOUND
Cotinus coggygria compound preparation and use
InactiveCN101485751BGood treatment effectImprove hypoxia toleranceOrganic active ingredientsAntipyreticDiseaseAntithrombotic Agent
The invention relates to a cotinus coggygria scop compound preparation, which is prepared from cotinus coggygria scop, rhizoma corydalis and hawkthorn in proportion, wherein the dosage of the cotinus coggygria scop is equal to that of the hawkthorn, and the dosage of the rhizoma corydalis is not more than 2 / 3 of that of the cotinus coggygria scop or the hawkthorn. The cotinus coggygria scop compound preparation can be used as an anticoagulant and antithrombotic drug, an abirritation drug, a drug for activating blood circulation to dissipate blood stasis and reducing the whole blood viscosity,a drug for improving the organism anti-hypoxia effect, and a drug for treating coronary heart disease or coronarism or miocardial infarction. The cotinus coggygria scop compound preparation not only improves the curative effect of the cotinus coggygria scop, but also reduces the dosage, and is used for easing pain and treating cardiovascular and cerebrovascular disease. Comparative experiments prove that the compound preparation has equivalent anticoagulant activity and abirritation as aspirin, and has the function of organism hypoxia resistance.
Owner:龙丽辉 +1
Medicament composition and preparation method for treating chronic glomerulonephritis
ActiveCN101632772BUrinary disorderLeech/worm material medical ingredientsCreatinine riseCrescentic glomerulonephritis
The invention discloses a medicament composition and a preparation method for treating chronic glomerulonephritis. The medicament composition comprises the components of raw material medicament based on portions by weight: 450 to 550 portions of milk veteh, 200 to 300 portions of angelica, 330 to 430 portions of yam, 200 to 300 portions of bupleurum, 250 to 350 portions of pyrrosia lingua, 250 to350 portions of umbellate pore furgus and 50 to 100 portions of leech. The medicament composition has obvious effect on treating chronic glomerulonephritis, raises high cutting and low cutting of whole blood viscosity, blood plasma and red cell accumulation, reduces the levels of the total protein and the albumin of blood, raises the levels of the nitrogen and the creatinine of blood urea, improves blood haemorheology and raises urinary output by 3h and total urinary output.
Owner:CHINA JAPAN FRIENDSHIP HOSPITAL
Traditional Chinese medicine composition for treatment of hemorrhoid and preparation method thereof
InactiveCN102940679ACreep slowlyImprove microcirculationCardiovascular disorderPlant ingredientsBile fluidHemorrhoids
Provided are a traditional Chinese medicine composition for treatment of hemorrhoid and a preparation method thereof. The composition is prepared by 15%-25% of astragalus membranaceus, 8%-15% of the root of kudzu vine, 15%-25% of caltrop, 30%-50% of Chinese mahonia stem, 15%-25% of radix angelicae, 0.5%-2% of pig bile, and l%-5% of borneol?. The preparation method includes removing impurity form astragalus membranaceus, the root of kudzu vine, caltrop, Chinese mahonia stem and radix angelicae, and weighing for using, sterilizing a half amount of radix angelicae, extracting the remained radix angelicae, astragalus membranaceus, the root of kudzu vine, caltrop and Chinese mahonia stem to get a filtrate, adding pig bile to the filtrate, concentrating in a concentrator to get thick paste, and drying the thick paste to get the traditional Chinese medicine composition. The traditional Chinese medicine composition has the functions of heat-clearing and detoxifying, removing slough and promoting growth of tissue regeneration, improving blood circulation, and improving blood viscosity, hematocrit and whole blood viscosity, so that the osmotic pressure returns to normal. The composition can nitrate nerves, inhibit various pathogenic bacterial growth and kill bacteria, promote the growth of granulation tissue, promote wound healing, and prevent elderly people from the pain of surgical trauma.
Owner:GUANGXI JIAJIN PHARMA
Medicinal composition for treating cardio-cerebral vascular disease and its preparing method
ActiveCN1943584AWith promoting blood circulation and removing blood stasisReduce blood viscosityOrganic active ingredientsCardiovascular disorderVascular diseaseDaidzin
The invention discloses a compound medication for treatment of brain and cranial vascular disease and said medication comprises components as follows:onocol -7-O-glucoside 4.5-5.5,daidzin 6.7-8.2 , 3'-methoxy puerarin 4.5-5.5, puerarin 44-54,sissotorin 2.7-3.3,puerarin -4'-O- glucoside 3-3.7, glucoside 0.4-0.5, etc. Said inventive medical compound can be prepared into clinical proper drugs in accordance with means of preparation for convention ones.
Owner:INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI +1
Cotinus coggygria compound preparation and use
InactiveCN101485751AGood treatment effectImprove hypoxia toleranceOrganic active ingredientsAntipyreticDiseaseAntithrombotic Agent
The invention relates to a cotinus coggygria scop compound preparation, which is prepared from cotinus coggygria scop, rhizoma corydalis and hawkthorn in proportion, wherein the dosage of the cotinus coggygria scop is equal to that of the hawkthorn, and the dosage of the rhizoma corydalis is not more than 2 / 3 of that of the cotinus coggygria scop or the hawkthorn. The cotinus coggygria scop compound preparation can be used as an anticoagulant and antithrombotic drug, an abirritation drug, a drug for activating blood circulation to dissipate blood stasis and reducing the whole blood viscosity, a drug for improving the organism anti-hypoxia effect, and a drug for treating coronary heart disease or coronarism or miocardial infarction. The cotinus coggygria scop compound preparation not only improves the curative effect of the cotinus coggygria scop, but also reduces the dosage, and is used for easing pain and treating cardiovascular and cerebrovascular disease. Comparative experiments prove that the compound preparation has equivalent anticoagulant activity and abirritation as aspirin, and has the function of organism hypoxia resistance.
Owner:龙丽辉 +1
Traditional Chinese medicine recipe for treating rheumatoid arthritis
InactiveCN102512601AImprove coagulation stateReduce viscosityAntipyreticAnalgesicsMonkshoodsSide effect
The invention discloses a traditional Chinese medicine recipe for treating rheumatoid arthritis, which relates to the field of traditional Chinese medicine preparations. The traditional Chinese medicine recipe for treating the rheumatoid arthritis is characterized by comprising sixteen traditional Chinese medicines: Angelica sinensis, Radix rehmanniae Preparata, Ligusticum wallichii, radix paeoniae alba, radices sileris, notopterygium root, frankincense, myrrh, Monkshood, dried tangerine or orange peel, cassia twig, liquorice, Caulis Spatholobi, Radix Salviae Miltiorrhizae, Rhizoma Gastrodiae and Pangolin Scales. The sixteen traditional Chinese medicines are taken three times a day after being soaked in white wine for 7 days. The invention has the beneficial effects that the traditional Chinese medicine recipe for treating the rheumatoid arthritis is capable of effectively promoting blood circulation and removing blood stasis, freeing channels and stopping pains and improving the symptom of blood stasis. The whole blood viscosity and the plasma viscosity are reduced, red blood cell aggregations are reduced, and the plasma proteins are reduced; an obvious inhibitory action is performed on adenosine diphosphate (ADP)-induced platelet aggregations, agglomerate platelets can be rapidly depolymerized, and the red blood cell aggregations in microcirculation are delayed and relieved, thereby, the blood viscosity is reduced, the blood agglomeration state is improved, blood vessels are dilated, smooth muscle spasm is relieved and the pains are relieved. The traditional Chinese medicine recipe disclosed by the invention is a pure traditional Chinese medicine preparation, does not have toxic and side effects and has an obvious effect.
Owner:徐海洋
Traditional Chinese medicine composition for treating chilblain and preparation method thereof
InactiveCN105582455AMild therapeutic effectSmall side effectsUnknown materialsPill deliveryAmomum villosumRhizome
The invention discloses a traditional Chinese medicine composition for treating chilblain and a preparation method thereof. The composition is prepared from the following raw materials: motherwort, false nettleleaf pepper herb, red sage root, white peony root, gerbera piloselloides, tuckahoe, honey-baked licorice, prepared rehmannia root, Chinese yam, cassia, vinegar-baked nutgrass galingale rhizome, honey-baked astragalus root, angelica, vinegar-prepared corydalis tuber, fructus amomi, chuanxiong rhizome, hot ass-hide glue, teasel root, baikal skullcap root, bighead atractylodes rhizome, costus root, dangshen and cornu cervi degelatinatum. Animal pharmacodynamic experiment results show that the traditional Chinese medicine composition can obviously reduce the whole blood viscosity, packed cell volume, plasma viscosity and level of blood coagulation factors I of frostbitten rats. By virtue of the experiment results, the traditional Chinese medicine composition has a function of treating chilblain.
Owner:GUANGXI WUZHOU PHARMA GRP
Medicinal liquor for treating gout and preparation method of medicinal liquor
InactiveCN106038881AAnti-tumorAnti-fatigueDispersion deliveryAnthropod material medical ingredientsAlcoholMedicine
The invention provides medicinal liquor for treating gout and a preparation method of the medicinal liquor, and belongs to the technical field of medicinal liquor preparation. The medicinal liquor mainly comprises geckos, cortex acanthopanacis, eucommia ulmoides, belvedere fruits, caulis sinomenii, silkworm excrement, cassia twigs, homalomena occulta, mirabilite, tiger-bone, mistletoe and centella asiatica. According to the preparation method, two animal drugs including the geckos and the tiger-bone are soaked in edible alcohol, other plant herbs are soaked in yellow rice wine and rice wine, the mineral drug mirabilite is added, and the medicinal liquor is obtained after mixing and soaking. The medicinal liquor has the advantages of the effect of clearing heat, promoting dieresis, dispelling the wind, strengthening bone, promoting blood circulation and dredging collaterals, the function of resisting tumor and fatigue, reducing whole blood viscosity and preventing atherosclerosis, and the like.
Owner:靖西市民族医药协会
Traditional Chinese medicine composition for decreasing blood fat and preparation method
ActiveCN108159146AAvoid heavy useReduce blood lipid lowering effectMetabolism disorderPlant ingredientsOrganic solventTG - Triglyceride
The invention relates to the field of medicines, and particularly relates to a medicine and an extracting technology thereof. The extracting technology is characterized in that water is selected as asolvent, so that organic solvents can be greatly saved, and the environmental protection as well as the safety can be ensured; in addition, the low-temperature and high-pressure-difference extractingway is carried out, so that effective components can be extracted to the maximum, and as a result, the production efficiency is improved. The pharmacological research result shows that a traditional Chinese medicine composition prepared according to the extracting technology is capable of obviously reducing high cholesterol, caused by egg nog, of a mice, obviously improving hemorheology of a tested rat with hyperlipemia, decreasing whole blood viscosity, decreasing cholesterol, triglyceride and low density lipoprotein content in blood serum, and obviously decreasing the blood fat; the fat decreasing effect is obviously greater than that of Jiangzhining particles under the same dosage.
Owner:XIUZHENG PHARMA GRP CHANGCHUN HIGH NEW PHARMA CO LTD
Goat yogurt suitable for being drunk by pregnant woman and preparation method of goat yogurt
InactiveCN106615108AReduce blood viscosityWith disease prevention and health careMilk preparationFlavorInulin
The invention provides goat yogurt suitable for being drunk by a pregnant woman. The goat yogurt comprises, by weight, 500-700 parts of fresh goat milk, 8-14 parts of zymophyte, 60-85 parts of whey protein, 0.02-0.06 part of escargot extract, 0.2-0.8 part of pine pollen disruption powder, 2-5 parts of compound vitamin, 0.3-0.7 part of DHA (docosahexaenoic acid), 4-8 parts of stabilizing agents, 4-12 parts of inulin and 0.1-0.3 part of Chinese mugwort leaf extracts. The invention further provides a preparation method of the goat yogurt suitable for being drunk by the pregnant woman. The preparation method includes the steps: removing goat flavor; fermenting mixture. The goat yogurt has the function of reducing whole blood viscosity of blood, a rat is lavaged with the goat yogurt for one week, whole blood specific viscosity low shear is 4.0-4.6mPa.s<-1>, whole blood specific viscosity middle shear is 10.1-12.9mPa.s<-1>, and whole blood specific viscosity high shear is 15.2-17.5mPa.s<-1>.
Owner:山东坤泰生物科技有限公司
Medicine for treating cerebral infarction, coronary heart disease and angina pectoris
InactiveCN1772059AReduce infarct sizeReduce resistancePill deliveryCapsule deliveryCoronary heart diseaseCerebral flow
The medicine for treating cerebral infarction, coronary heart disease and angina pectoris is prepared with red peony root in 1 weight portions and notoginseng in 2-6 weight portions as material. Animal experiments show that the medicine of the present invention can reduce cerebral infarction area, increase cerebral flow, reduce cerebral vascular resistance, resist acute myocardial ischemia, increase blood flow of coronary artery, reduce thromosis, lower fibrinogen, blood viscosity, etc.
Owner:马耀茹
Whole blood viscosity measuring device
ActiveCN108169074AWith automated functionsAvoid errorsFlow propertiesHydraulic cylinderElectromagnet
The invention relates to the field of medical instruments and particularly relates to a whole blood viscosity measuring device. The upper parts of a first support and a second support are provided with strip-shaped holes. A support rod is movably inserted into the strip-shaped hole. The lower side wall of the support rod in the strip-shaped hole is fixedly connected to a first spring. The other end of the first spring is fixedly connected to the inner wall of the lower end of the strip-shaped hole. A second electromagnet is fixedly installed to the inner wall of the lower end of the second support in the strip-shaped hole. The support rod is sleeved by a first sleeve. A sampling box is connected to the outer side wall of the first sleeve. The sampling box is provided with multiple samplingpin holes. A sampling pin is movably inserted into the sampling pin hole. Blood sample test tube fixing racks are arranged in middles of the first support and the second support. A blood rheology measuring device is installed on a blood rheology device fixing rack. The upper end surface of a base is connected to a hydraulic cylinder fixing rack. The upper end of the hydraulic cylinder fixing rackis fixedly connected to a hydraulic cylinder. The other end of the hydraulic cylinder is fixedly connected to a sampling box clamper. The whole blood viscosity measuring device is easy to operate, produces accurate detection results and has strong practicability.
Owner:合肥安为康医学检验有限公司
Method and device for detecting blood viscosity and hematocrit by using one instrument
ActiveCN101995364BReduce usageReduce cleaning workloadVolume measurement apparatus/methodsDirect flow property measurementMeasurement deviceAutomatic control
The invention relates to a method and a device for detecting blood viscosity and hematocrit by using one instrument. In the invention, full-automatic detection equipment, including a stirring pin device, a sample loading pin device, a capillary viscosity measurement device, a rotary type blood rheological measurement device, a hematocrit scanning measurement device, a computer device based automatic control circuit and a matched program of the automatic control circuit is used. The detection method comprises the following steps of: collecting a patient blood sample, carrying out anticoagulantprocessing, injecting into a sample tube, and centrifuging; putting the sample tube in a sample tube frame, conveying the sample tube frame to a hematocrit test position for detecting, and storing hematocrit data; conveying the sample tube frame to a blood viscosity test position for detecting plasm viscosity and storing data; stirring the blood sample into whole blood by the stirring pin device,and reading the blood viscosity data by the rotary type blood rheological measurement device; and processing the detected data by a resolving processor. By using the full-automatic detection manner disclosed in the invention, operators avoid contacting the patient blood sample directly and cannot be polluted, all the processes of sample loading process, detection process and cleaning process are all accomplished by instruments automatically, thereby improving the detection speed and accuracy of clinical examination.
Owner:BEIJING PRECIL INSTR CO LTD
Method for automatically measuring blood viscosity
ActiveCN101819124BAvoid human errorEasy to operateDirect flow property measurementMedicineData acquisition
The invention relates to a method for automatically measuring blood viscosity, which comprises the following steps of: acquiring data by using a full-automatic blood rheometer, wherein the blood rheometer comprises a capillary viscosity measuring device, a rotary blood rheology measuring device and a blood mixing device; centrifuging a blood sample by using a centrifugal machine to completely separate blood cells from blood plasma; starting the capillary viscosity measuring device to measure the viscosity of a blood plasma sample; re-injecting the used blood plasma sample into a sample tube; uniformly mixing the blood samples into a whole-blood state; starting a sampling needle to suck the whole blood from the sample tube and injecting the whole blood into the rotary blood rheology measuring device, and measuring the viscosity of the whole blood; and processing the measured data by using a resolving processor to generate a measuring report. The method for automatically measuring the blood viscosity eliminates manual operation error, simplifies operation steps, and shortens test time.
Owner:BEIJING PRECIL INSTR CO LTD
A kind of pharmaceutical composition for treating chloasma and preparation method thereof
ActiveCN104173607BIncrease viscosityLower whole blood viscosity valuesDermatological disorderPlant ingredientsLiver and kidneySide effect
The invention relates to a pharmaceutical composition for treating chloasma and a preparation method thereof. It is mainly prepared from the extracts of Ligustrum lucidum, Eclipta chinensis, Salvia miltiorrhiza, Angelica, cinnamon, rose, and grape seed. It has the effects of nourishing the liver and kidney, removing blood stasis and eliminating spots, and is suitable for patients with chloasma. Clinical studies have shown that the present invention can significantly improve the symptoms of patients with chloasma, the total clinical effective rate is 91.43%, and no toxic or side effects have been seen; experimental studies have shown that the present invention can significantly reduce the whole blood viscosity of chloasma mice and improve blood viscosity , Improve the activity of free radical scavenging enzymes, reduce lipid peroxidation, and reduce the production of melanin.
Owner:BEIJING UNIV OF CHINESE MEDICINE +1
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com